VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
-12.86%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
10 Year Return
AUM
$152M
AUM Growth
+$152M
Cap. Flow
+$56.5M
Cap. Flow %
37.18%
Top 10 Hldgs %
77.62%
Holding
22
New
7
Increased
1
Reduced
4
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$24.5M 16.12% +1,035,657 New +$24.5M
PDSB icon
2
PDS Biotechnology
PDSB
$57.8M
$17.7M 11.64% 1,933,582
ASND icon
3
Ascendis Pharma
ASND
$11.8B
$13.4M 8.8% 721,152
BCRX icon
4
BioCryst Pharmaceuticals
BCRX
$1.74B
$13.3M 8.73% +4,689,435 New +$13.3M
RGNX icon
5
Regenxbio
RGNX
$451M
$11.1M 7.32% 1,030,954
HRTX icon
6
Heron Therapeutics
HRTX
$207M
$7.71M 5.07% +405,901 New +$7.71M
CTMX icon
7
CytomX Therapeutics
CTMX
$336M
$7.43M 4.89% 577,831 -25,200 -4% -$324K
CHRS icon
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$5.5M 3.62% 259,259
AKTX
9
Akari Therapeutics
AKTX
$24.8M
$5.17M 3.4% 369,490
SIOX
10
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$4.93M 3.24% +429,590 New +$4.93M
ARCT icon
11
Arcturus Therapeutics
ARCT
$462M
$4.29M 2.82% 1,130,500
LPCN icon
12
Lipocine
LPCN
$15.8M
$4.26M 2.8% 420,000
ORKA
13
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$3.74M 2.46% 1,078,932
ONC
14
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$3.49M 2.29% +119,000 New +$3.49M
OCRX
15
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.79M 1.83% +948,372 New +$2.79M
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.7M 1.78% 170,312 +28,701 +20% +$455K
STML
17
DELISTED
Stemline Therapeutics, Inc.
STML
$1.47M 0.97% 315,980
ADVM icon
18
Adverum Biotechnologies
ADVM
$64.6M
$1.45M 0.95% 280,000
LRMR icon
19
Larimar Therapeutics
LRMR
$310M
$945K 0.62% +141,479 New +$945K
SRRA
20
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$882K 0.58% 130,798 -44,202 -25% -$298K